Intellia (NTLA) is a publicly traded Healthcare sector company. As of September 21, 2026, NTLA trades at $12.12 with a market cap of $1.70B and a P/E ratio of -3.62. NTLA moved -1.06% today. Year to date, NTLA is +35.04%; over the trailing twelve months it is -24.64%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is buy with an average price target of $20.50. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NTLA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $12.12 |
| Market Cap | $1.70B |
| P/E Ratio | -3.62 |
| EPS | $-3.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.25 |
| 52-Week Low | $5.90 |
| Volume | 4.94M |
| Avg Volume | 0 |
| Revenue (TTM) | $59.51M |
| Net Income | $-399.98M |
| Gross Margin | 0.00% |
12 analysts cover NTLA: 0 strong buy, 6 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.50.